Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), NCR3 agonists(natural cytotoxicity triggering receptor 3 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
B-Cell Lymphoma | Discovery | DK | - | |
B-Cell Lymphoma | Discovery | DE | - |